Myrbetriq (mirabegron) is a prescription drug that’s used to treat certain bladder problems. This drug can interact with other medications. For example, Myrbetriq can interact with metoprolol ...

Myrbetriq – sold as Betanis and Betmiga in ... with around $650 million in US sales to competition. US sales of the drug plummeted 89% in the first nine months of the current fiscal year.

Vraylar (cariprazine) is a prescription drug that’s used to treat certain mental health conditions, such as schizophrenia. The drug comes as a capsule that you swallow. It’s usually taken once ...

A US district court has said that a key patent held by Astellas on its Myrbetriq drug for urinary incontinence is invalid, in a setback to its efforts to defend the blockbuster therapy from ...

Check with your pharmacist if you have questions about storing finasteride. The most common side effects of finasteride are listed below. Tell your healthcare provider if you have any of these ...

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial ...

Wegovy (semaglutide) is a brand-name drug prescribed for weight management in adults and some children. Wegovy comes as a solution in single-use injection pens. It’s typically injected once per ...

The average drug now costs more than US$1 billion to develop and takes more than a decade to reach the market 1 . And for every success, there are nine drug candidates that fail clinical trials 2 ...

A team has designed a new drug against malaria and identified its mechanism of action. In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent ...

Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...

Holly Geyer, an addiction medicine specialist and the lead physician of the Mayo Clinic opioid stewardship program in Arizona, explains that in an effort to help combat opioid-related drug abuse ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on ...